These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
x
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
|
|
|
EXCHANGE ACT OF 1934
|
||
|
For the quarterly period ended March 31, 2011
|
||
|
OR
|
||
|
¨
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
|
|
|
EXCHANGE ACT OF 1934
|
||
|
For the transition period from ________________ to ________________
|
|
Delaware
|
13-3475943
|
|
|
(State or other jurisdiction of
|
(I.R.S. Employer
|
|
|
incorporation or organization)
|
Identification No.)
|
|
|
Three University Plaza
|
07601
|
|
|
Hackensack, New Jersey
|
(Zip Code)
|
|
|
(Address of principal executive offices)
|
|
Page No.
|
||
|
|
||
|
Item 1.
|
Condensed Consolidated Financial Statements (Unaudited):
|
|
|
Condensed Consolidated Balance Sheets as of March 31, 2011 and December 31, 2010
|
1
|
|
|
Condensed Consolidated Statements of Operations for the three months ended
March 31, 2011 and 2010
|
2
|
|
|
Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2011 and 2010
|
3
|
|
|
Condensed Consolidated Statement of Stockholders’ Equity for the three months ended March 31, 2011 and 2010
|
4
|
|
|
Notes to Condensed Consolidated Financial Statements
|
5
|
|
|
Item 2.
|
Management’s Discussion and Analysis of Financial Condition and Results of Operations
|
14
|
|
Item 3.
|
Quantitative and Qualitative Disclosures about Market Risk
|
20
|
|
Item 4.
|
Controls and Procedures
|
21
|
|
|
||
|
Item 1.
|
Legal Proceedings
|
22
|
|
Item 1A.
|
Risk Factors
|
22
|
|
Item 2.
|
Unregistered Sales of Equity Securities and Use of Proceeds
|
22
|
|
Item 3.
|
Defaults Upon Senior Securities
|
22
|
|
Item 4.
|
Reserved
|
22
|
|
Item 5.
|
Other Information
|
22
|
|
Item 6.
|
Exhibits
|
23
|
|
Signatures
|
24
|
|
|
March 31,
2011
|
December 31,
2010
|
|||||||
|
ASSETS
|
||||||||
|
Current assets:
|
||||||||
|
Cash and cash equivalents
|
$ | 14,379 | $ | 14,120 | ||||
|
Short term investments - other
|
8,547 | 8,875 | ||||||
|
Accounts receivable, net
|
8,004 | 8,389 | ||||||
|
Prepaid expenses and other current assets
|
3,350 | 3,842 | ||||||
|
Deferred income taxes
|
1,479 | 1,581 | ||||||
|
Total current assets
|
35,759 | 36,807 | ||||||
|
Property and equipment, net
|
4,120 | 4,284 | ||||||
|
Other assets
|
2,602 | 2,684 | ||||||
|
Long term investments – other
|
5,674 | 5,000 | ||||||
|
Deferred income taxes
|
3,333 | 2,797 | ||||||
|
Goodwill
|
675 | 675 | ||||||
|
Total assets
|
$ | 52,163 | $ | 52,247 | ||||
|
LIABILITIES AND STOCKHOLDERS’ EQUITY
|
||||||||
|
Current liabilities:
|
||||||||
|
Accounts payable
|
$ | 987 | $ | 855 | ||||
|
Accrued expenses
|
1,936 | 2,192 | ||||||
|
Accrued salaries, wages and related benefits
|
4,808 | 4,870 | ||||||
|
Income and other taxes
|
1,908 | 1,852 | ||||||
|
Current portion of long term obligations
|
215 | 458 | ||||||
|
Deferred income taxes
|
432 | 492 | ||||||
|
Total current liabilities
|
10,286 | 10,719 | ||||||
|
Deferred income taxes
|
153 | 137 | ||||||
|
Income and other taxes – long term
|
360 | 349 | ||||||
|
Long term obligations
|
1,914 | 1,604 | ||||||
|
Commitments and contingencies
|
||||||||
|
STOCKHOLDERS’ EQUITY
:
|
||||||||
|
Serial preferred stock; 5,000,000 shares authorized, none outstanding
|
- | - | ||||||
|
Common stock, $.01 par value; 75,000,000 shares authorized; 26,207,000 shares issued
and 25,155,000 outstanding at March 31, 2011 and December 31, 2010
|
262 | 262 | ||||||
|
Additional paid-in capital
|
20,597 | 20,523 | ||||||
|
Retained earnings
|
20,427 | 20,412 | ||||||
|
Accumulated other comprehensive income
|
1,125 | 1,202 | ||||||
| 42,411 | 42,399 | |||||||
|
Less: treasury stock, 1,052,000 shares at cost
|
(2,961 | ) | (2,961 | ) | ||||
|
Total stockholders’ equity
|
39,450 | 39,438 | ||||||
|
Total liabilities and stockholders’ equity
|
$ | 52,163 | $ | 52,247 | ||||
|
Three Months Ended
|
||||||||
|
March 31,
|
||||||||
|
2011
|
2010
|
|||||||
|
Revenues
|
$ | 14,701 | $ | 15,474 | ||||
|
Operating costs and expenses:
|
||||||||
|
Direct operating costs
|
10,673 | 12,272 | ||||||
|
Selling and administrative expenses
|
4,053 | 4,135 | ||||||
|
Interest income, net
|
(109 | ) | (2 | ) | ||||
|
Totals
|
14,617 | 16,405 | ||||||
|
Income (loss) before provision for income taxes
|
84 | (931 | ) | |||||
|
Provision for income taxes
|
69 | 473 | ||||||
|
Net income (loss)
|
$ | 15 | $ | (1,404 | ) | |||
|
Income (loss) per share:
|
||||||||
|
Basic and diluted
|
$ | - | $ | (.06 | ) | |||
|
Weighted average shares outstanding:
|
||||||||
|
Basic
|
25,155 | 25,379 | ||||||
|
Diluted
|
25,414 | 25,379 | ||||||
|
Three Months Ended
|
||||||||
|
March 31,
|
||||||||
|
2011
|
2010
|
|||||||
|
Cash flow from operating activities:
|
||||||||
|
Net income (loss)
|
$ | 15 | $ | (1,404 | ) | |||
|
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
|
||||||||
|
Depreciation and amortization
|
800 | 956 | ||||||
|
Stock-based compensation
|
74 | 21 | ||||||
|
Deferred income taxes
|
(442 | ) | (31 | ) | ||||
|
Pension cost
|
140 | 101 | ||||||
|
Changes in operating assets and liabilities:
|
||||||||
|
Accounts receivable
|
385 | 1,300 | ||||||
|
Prepaid expenses and other current assets
|
356 | (105 | ) | |||||
|
Other assets
|
(35 | ) | (103 | ) | ||||
|
Accounts payable and accrued expenses
|
(124 | ) | (684 | ) | ||||
|
Accrued salaries, wages and related benefits
|
(62 | ) | (107 | ) | ||||
|
Income and other taxes
|
67 | 467 | ||||||
|
Net cash provided by operating activities
|
1,174 | 411 | ||||||
|
Cash flow from investing activities:
|
||||||||
|
Capital expenditures
|
(519 | ) | (873 | ) | ||||
|
Purchase of investments - other
|
(346 | ) | - | |||||
|
Net cash used in investing activities
|
(865 | ) | (873 | ) | ||||
|
Cash flow used in financing activities:
|
||||||||
|
Payment of long term obligations
|
(50 | ) | (188 | ) | ||||
|
Increase (decrease) in cash and cash equivalents
|
259 | (650 | ) | |||||
|
Cash and cash equivalents, beginning of period
|
14,120 | 26,480 | ||||||
|
Cash and cash equivalents, end of period
|
$ | 14,379 | $ | 25,830 | ||||
|
Supplemental disclosures of cash flow information:
|
||||||||
|
Cash paid for income taxes
|
$ | 283 | $ | 107 | ||||
|
Accumulated
|
||||||||||||||||||||||||||||
|
Additional
|
Other
|
|||||||||||||||||||||||||||
|
Common Stock
|
Paid-in
|
Retained
|
Comprehensive
|
Treasury
|
||||||||||||||||||||||||
|
Shares
|
Amount
|
Capital
|
Earnings
|
Income
|
Stock
|
Total
|
||||||||||||||||||||||
|
January 1, 2011
|
25,155 | $ | 262 | $ | 20,523 | $ | 20,412 | $ | 1,202 | $ | (2,961 | ) | $ | 39,438 | ||||||||||||||
|
Net income
|
- | - | - | 15 | - | - | 15 | |||||||||||||||||||||
|
Stock-based compensation
|
- | - | 74 | - | - | - | 74 | |||||||||||||||||||||
|
Pension liability adjustments, net of taxes
|
- | - | - | - | 9 | - | 9 | |||||||||||||||||||||
|
Change in fair value of derivatives, net of taxes
|
- | - | - | - | (86 | ) | - | (86 | ) | |||||||||||||||||||
|
March 31, 2011
|
25,155 | $ | 262 | $ | 20,597 | $ | 20,427 | $ | 1,125 | $ | (2,961 | ) | $ | 39,450 | ||||||||||||||
|
January 1, 2010
|
25,379 | $ | 262 | $ | 20,267 | $ | 21,159 | $ | 1,486 | $ | (2,189 | ) | $ | 40,985 | ||||||||||||||
|
Net loss
|
- | - | - | (1,404 | ) | - | - | (1,404 | ) | |||||||||||||||||||
|
Stock-based compensation
|
- | - | 19 | - | - | - | 19 | |||||||||||||||||||||
|
Issuance of restricted shares
|
40 | - | 2 | - | - | - | 2 | |||||||||||||||||||||
|
Pension liability adjustments, net of taxes
|
- | - | - | - | (3 | ) | - | (3 | ) | |||||||||||||||||||
|
Change in fair value of derivatives, net of taxes
|
- | - | - | - | 305 | - | 305 | |||||||||||||||||||||
|
March 31, 2010
|
25,419 | $ | 262 | $ | 20,288 | $ | 19,755 | $ | 1,788 | $ | (2,189 | ) | $ | 39,904 | ||||||||||||||
|
INNODATA ISOGEN, INC. AND SUBSIDIARIES
|
|
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
|
|
THREE MONTHS ENDED MARCH 31, 2011 AND 2010
|
|
(Unaudited)
|
|
1.
|
Description of Business and Summary of Significant Accounting Policies
|
|
INNODATA ISOGEN, INC. AND SUBSIDIARIES
|
|
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
|
|
THREE MONTHS ENDED MARCH 31, 2011 AND 2010
|
|
(Unaudited)
|
|
2.
|
Income taxes
|
|
Unrecognized tax
benefits
|
||||
|
Balance - January 1, 2011
|
$
|
1,827
|
||
|
Interest accrual
|
23
|
|||
|
Balance – March 31, 2011
|
$
|
1,850
|
||
|
INNODATA ISOGEN, INC. AND SUBSIDIARIES
|
|
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
|
|
THREE MONTHS ENDED MARCH 31, 2011 AND 2010
|
|
(Unaudited)
|
|
3.
|
Commitments and contingencies
|
|
INNODATA ISOGEN, INC. AND SUBSIDIARIES
|
|
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
|
|
THREE MONTHS ENDED MARCH 31, 2011 AND 2010
|
|
(Unaudited)
|
|
4.
|
Stock options
|
|
Number of Shares
|
Weighted-Average
Exercise Price
|
Weighted-Average
Remaining
Contractual
Term (years)
|
Aggregate
Intrinsic
Value
|
|||||||||||||
|
Outstanding at January 1, 2011
|
2,096,780 | $ | 2.83 | |||||||||||||
|
Granted
|
195,000 | $ | 2.41 | |||||||||||||
|
Exercised
|
— | — | ||||||||||||||
|
Forfeited/Expired
|
(4,451 | ) | $ | 3.51 | ||||||||||||
|
Outstanding at March 31, 2011
|
2,287,329 | $ | 2.79 | 4.30 | $ | 643,000 | ||||||||||
|
Exercisable at March 31, 2011
|
1,880,499 | $ | 2.67 | 3.16 | $ | 639,000 | ||||||||||
|
Three months ended
|
||||||||
|
March 31,
|
||||||||
|
2011
|
2010
|
|||||||
|
Weighted average fair value of options granted
|
$ | 1.82 | $ | 3.54 | ||||
|
Risk-free interest rate
|
2.83 | % | 3.19 | % | ||||
|
Expected life (years)
|
8.00 | 8.00 | ||||||
|
Expected volatility factor
|
74 | % | 90 | % | ||||
|
Expected dividends
|
None
|
None
|
||||||
|
Three months ended March 31,
|
||||||||
|
2011
|
2010
|
|||||||
|
Direct operating costs
|
$ | 1 | $ | 3 | ||||
|
Selling and adminstrative expenses
|
73 | 18 | ||||||
|
Total stock-based compensation
|
$ | 74 | $ | 21 | ||||
|
INNODATA ISOGEN, INC. AND SUBSIDIARIES
|
|
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
|
|
THREE MONTHS ENDED MARCH 31, 2011 AND 2010
|
|
(Unaudited)
|
|
5.
|
Comprehensive loss
|
|
Three months ended
|
||||||||
|
March 31,
|
||||||||
|
2011
|
2010
|
|||||||
|
Net income (loss)
|
$ | 15 | $ | (1,404 | ) | |||
|
Pension liability (loss) adjustment, net of taxes
|
9 | (3 | ) | |||||
|
Unrealized gain from derivatives, net of taxes
|
(86 | ) | 305 | |||||
|
Comprehensive loss
|
$ | (62 | ) | $ | (1,102 | ) | ||
|
Pension Liability
|
Fair value of
|
Accumulated Other
|
||||||||||
|
Adjustment
|
Derivatives
|
Comprehensive Income
|
||||||||||
|
Balance at January 1, 2011
|
$ | 379 | $ | 823 | $ | 1,202 | ||||||
|
Current-period change
|
9 | (86 | ) | (77 | ) | |||||||
|
Balance at March 31, 2011
|
$ | 388 | $ | 737 | $ | 1,125 | ||||||
|
6.
|
Segment reporting and concentrations
|
|
Three months ended
|
||||||||
|
March 31,
|
||||||||
|
2011
|
2010
|
|||||||
|
United States
|
$ | 9,284 | $ | 10,557 | ||||
|
United Kingdom
|
2,122 | 1,947 | ||||||
|
The Netherlands
|
2,192 | 1,870 | ||||||
|
Other - principally Europe
|
1,103 | 1,100 | ||||||
| $ | 14,701 | $ | 15,474 | |||||
|
INNODATA ISOGEN, INC. AND SUBSIDIARIES
|
|
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
|
|
THREE MONTHS ENDED MARCH 31, 2011 AND 2010
|
|
(Unaudited)
|
|
2011
|
2010
|
|||||||
|
United States
|
$ | 1,080 | $ | 1,066 | ||||
|
Foreign countries:
|
||||||||
|
Philippines
|
2,261 | 2,300 | ||||||
|
India
|
804 | 895 | ||||||
|
Sri Lanka
|
503 | 495 | ||||||
|
Israel
|
147 | 203 | ||||||
|
Total foreign
|
3,715 | 3,893 | ||||||
| $ | 4,795 | $ | 4,959 | |||||
|
7.
|
Income (loss) per share
|
|
Three months ended March 31,
|
||||||||
|
2011
|
2010
|
|||||||
|
(in thousands, except per share amounts)
|
||||||||
|
Net income (loss)
|
$ | 15 | $ | (1,404 | ) | |||
|
Weighted average common shares outstanding
|
25,155 | 25,379 | ||||||
|
Dilutive effect of outstanding stock awards
|
259 | — | ||||||
|
Adjusted for dilution computation
|
25,414 | 25,379 | ||||||
|
INNODATA ISOGEN, INC. AND SUBSIDIARIES
|
|
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
|
|
THREE MONTHS ENDED MARCH 31, 2011 AND 2010
|
|
(Unaudited)
|
|
8.
|
Derivatives
|
|
Asset Derivatives
|
||||||||||
|
Balance Sheet Location
|
Fair Value
|
|||||||||
|
2011
|
2010
|
|||||||||
|
Derivatives designated as hedging instruments:
|
||||||||||
|
Foreign currency forward contracts
|
Prepaid expenses and other current assets
|
$ | 1,168 | $ | 1,304 | |||||
|
INNODATA ISOGEN, INC. AND SUBSIDIARIES
|
|
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
|
|
THREE MONTHS ENDED MARCH 31, 2011 AND 2010
|
|
(Unaudited)
|
|
2011
|
2010
|
|||||||
|
Net gain recognized in OCI
(1)
|
$ | 224 | $ | 962 | ||||
|
Net gain reclassified from accumulated OCI into income
(2)
|
$ | 360 | $ | 512 | ||||
|
Net gain recognized in income
(3)
|
$ | — | $ | — | ||||
|
9.
|
Financial Instruments
|
|
|
·
|
Level 1
: Unadjusted quoted price in active market for identical assets and liabilities.
|
|
|
·
|
Level 2:
Observable inputs other than those included in Level 1.
|
|
|
·
|
Level 3:
Unobservable inputs reflecting management’s own assumptions about the inputs used in pricing the asset or liability.
|
|
March 31, 2011
|
Level 1
|
Level 2
|
Level 3
|
|||||||||
|
Assets
|
||||||||||||
|
Derivatives
|
$ | — | $ | 1,168 | $ | — | ||||||
|
December 31, 2010
|
Level 1
|
Level 2
|
Level 3
|
|||||||||
|
Assets
|
||||||||||||
|
Derivatives
|
$ | — | $ | 1,304 | $ | — | ||||||
|
INNODATA ISOGEN, INC. AND SUBSIDIARIES
|
|
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
|
|
THREE MONTHS ENDED MARCH 31, 2011 AND 2010
|
|
(Unaudited)
|
|
March 31, 2011
|
December 31, 2010
|
|||||||
|
Cash and cash equivalents
|
$ | 14,379 | $ | 14,120 | ||||
|
Short term and long term investments - other
|
14,221 | 13,875 | ||||||
|
Working capital
|
25,473 | 26,088 | ||||||
|
Payments Due by Period
|
||||||||||||||||||||
|
Contractual Obligations
|
Total
|
Less than
1 year
|
1-3 years
|
4-5 years
|
After
5 years
|
|||||||||||||||
|
Capital lease obligations
|
$ | 38 | $ | 38 | $ | - | $ | - | $ | - | ||||||||||
|
Non-cancelable operating leases
|
6,041 | 1,343 | 2,651 | 1,769 | 278 | |||||||||||||||
|
Total contractual cash obligations
|
$ | 6,079 | $ | 1,381 | $ | 2,651 | $ | 1,769 | $ | 278 | ||||||||||
|
Date:
|
May 2, 2011
|
/s/ Jack Abuhoff
|
|
|
Jack Abuhoff
|
|||
|
Chairman of the Board,
|
|||
|
Chief Executive Officer and President
|
|||
|
Date:
|
May 2, 2011
|
/s/ O’Neil Nalavadi
|
|
|
O’Neil Nalavadi
|
|||
|
Senior Vice President
|
|||
|
Chief Financial Officer
|
|||
|
and Principal Accounting Officer
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|